Extracorporeal treatment of metforminassociated lactic acidosis in clinical practice: a retrospective cohort study.

Inge R F van Berlo-van de LaarCornelis G VermeijMarjo van den Elsen-HuttenArthur de MeijerKatja TaxisFrank G A Jansman

Published in: European journal of clinical pharmacology (2020)

Although there was no statistical benefit in mortality shown from ECTR, ECTR might be lifesaving in MALA, considering the ECTR-group was significantly sicker than the non-ECTR-group. The majority of patients were treated in line with the EXTRIP criteria. Severity of lactic acidosis and renal impairment were the main indications for initiating ECTR.

Keyphrases

end stage renal disease
clinical practice
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
type diabetes
patient reported outcomes
cardiovascular disease
combination therapy